Ketryx Secures $39M Series B to Revolutionize AI-Powered Compliance in Life Sciences
Are life sciences companies struggling to balance teh speed of AI innovation with the stringent demands of regulatory compliance? Ketryx,an AI-powered compliance platform,is tackling this critical challenge head-on. today, the company announced a $39 million Series B funding round led by Change Capital, bringing its total funding to over $55 million. This investment signals a significant shift in how the life sciences industry approaches product development and validation in the age of artificial intelligence.
Ketryx isn’t just another software solution; it’s a foundational layer designed to accelerate the delivery of safer products while navigating the complex landscape of regulations governing medical devices,pharmaceuticals,and AI-driven healthcare solutions.This funding will fuel global expansion, accelerate product development, and bolster teams in Boston and Austria, positioning Ketryx as a key player in the future of regulated innovation.
The Growing Pain Point: Speed vs. Safety in Life Sciences
For decades, the life sciences industry has operated under a fundamental tension: the need to bring life-saving products to market quickly versus the imperative to ensure absolute safety and adherence to rigorous compliance standards. Traditionally, these goals have been seen as mutually exclusive. Extensive manual documentation, lengthy validation processes, and the inherent complexities of regulatory frameworks have created significant bottlenecks, delaying product releases and increasing costs.
The emergence of AI promises to dramatically accelerate product development, offering the potential for faster diagnoses, personalized treatments, and more efficient drug revelation. However, integrating AI into regulated environments introduces new layers of complexity. Ensuring the reliability,openness,and auditability of AI algorithms is paramount,and existing compliance processes frequently enough struggle to keep pace.
This is where Ketryx steps in.
Ketryx: AI-Powered Compliance for a New Era
Ketryx is redefining the product lifecycle for life science and medtech companies with a platform built specifically to address the challenges of AI-driven innovation. The platform seamlessly integrates into existing workflows, automating critical documentation tasks, establishing robust traceability, and accelerating release cycles.
Here’s how Ketryx is making a difference:
90% Reduction in Manual Work: By automating repetitive tasks, Ketryx frees up valuable time for scientists and engineers to focus on innovation.
10x Faster Product Releases: Streamlined workflows and real-time validation significantly reduce time-to-market.
Closing Compliance Gaps: The platform proactively identifies and addresses potential compliance issues, minimizing risk and ensuring adherence to regulations.
Zero-Lag Compliance: Ketryx introduces a paradigm shift with “zero-lag compliance,” where validation, traceability, and documentation occur in real-time throughout the entire development lifecycle.This eliminates the traditional lag between development and compliance, enabling faster, safer product releases.Already, Ketryx has earned the trust of three of the world’s top five medical device manufacturers, alongside Fortune 500 companies and innovative AI-driven enterprises like DeepHealth, Heartflow, and Aignostics. This demonstrates the platform’s ability to scale and meet the needs of diverse organizations operating in highly regulated environments.
The Vision: Becoming the AI Infrastructure Layer for Regulated Industries
According to Erez kaminski, CEO and Founder of Ketryx, “It’s now time to accelerate adoption and ensure AI is safe, reliable, and ready for the most regulated environments.” The company’s vision extends beyond simply automating compliance; it aims to become the essential AI infrastructure layer for regulated industries worldwide.
Vinay Shah, Partner and Founding Team Member at Transformation Capital, who will be joining Ketryx’s board, echoed this sentiment, highlighting the firm’s commitment to supporting the company’s growth and expansion. Transformation Capital’s deep expertise in digital health and industry connections will be invaluable as Ketryx navigates the evolving regulatory landscape and expands its global reach.
What does this meen for the future of life sciences? It means a future where innovation isn’t stifled by compliance, but rather enabled by it. Ketryx is paving the way for a new era of faster, safer, and more effective healthcare solutions.
Ready to learn more about how Ketryx can transform your compliance processes? Visit https://www.ketryx.com/ to request a demo.
Evergreen Insights: The Future of Compliance in a World of AI
The need for robust compliance frameworks will only intensify as AI becomes increasingly integrated into life sciences.Companies that proactively embrace AI-powered compliance solutions will gain a significant competitive advantage. Key trends to watch include:
*